Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Phase III Study of TK-041 (rupatadine) in Perennial Allergic Rhinitis
jRCT2080222900Phase 3
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of rupatadine in perennial rhinitis, sponsored by Teikoku Seiyaku Co., Ltd.
02
Drugs
rupatadine
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on jRCT2080222900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222900.